IIT-M’s ‘life-saving’ implant makes its way to the markets

In a significant breakthrough, researchers at the Indian Institute of Technology, Madras (IIT-M) have indigenously developed Asia’s first ‘life-saving’ implant called SynkroScaff — A Tissue Engineered

Published: 26th December 2016 02:25 AM  |   Last Updated: 26th December 2016 04:40 AM   |  A+A-

By Express News Service

CHENNAI: In a significant breakthrough, researchers at the Indian Institute of Technology, Madras (IIT-M) have indigenously developed Asia’s first ‘life-saving’ implant called SynkroScaff — A Tissue Engineered Bovine Pericardial Patch — for critical cardiovascular patients. Now, the technology, which has a global market, is being commercially exploited by a Chennai-based firm SynkroMax Biotech (SMBPL), for which a memorandum of understanding was signed last month.

The distinctive feature of the IIT-M pericardial patch (sack of buffalo’s heart) is that it has inherent properties of regeneration and integration in the body. While the existing ones used in India are processed using synthetic material and toxic chemicals, which can lead to calcification, the product IIT-M came up with uses biomaterial. Currently, India depends on imported surgical patches.
Soma Guhathakurta, IIT-M adjunct professor and director of SMBPL, said it had the potential to revolutionise the field of surgical patches with products designed and made in India. This has twin advantages. One, India’s dependence on imports will be eliminated and two, patients don’t have to undergo a second procedure to remove the sack after usage. None of the synthetic, homologous (human-derived) and xenogeneic (compatible animal-derived) patches have potential for growth and repair requiring re-operations.

Interestingly, development of SynkroScaff using indigenous technology originally sprouted out of Guhathakurta’s doctoral research in IIT-M in 2004, under the guidance of Venkatesh Balasubramanian, professor, Department of Engineering Design. She claims that the product has got versatile use to achieve anatomical correction of the heart and its blood vessels’ deformities and deficiencies. “Its applications are immense in cardiovascular and other surgical practices. We obtained the licence for the product in May this year. So far, 800 patches have been manufactured and over 12 surgeons are using them across India. Apollo Hospitals, Kauvery Hospital in Chennai and AIIMS in Delhi  are using it. We have also enrolled for Central Medical Services Society (CMSS) recognition of the product. The feedback from doctors and patients has been encouraging, with a 100 per cent success rate,” she said, adding that the product is manufactured in a facility complying with drug applications and current good manufacturing practice (cGMP) guidelines.

Venkatesh Balasubramanian, who mentored Guhathakurta, said, “It is always a desire that the philosophical work done as a doctoral thesis is inventive and innovative.  This was possible by an innovative processing of xenogeneic tissue for human usage. While the doctoral work won the best thesis award from Indian National Science Academy (INSA) in 2008, the true victory is when it is available as a surgical patch for the world, made in India. It is a pleasure that Soma Guhathakurtha and SMBPL are taking this technology to offer SynkroScaff, a product conceived, researched, designed, developed and made in India, for the world.” Balasubramanian said the cost of imported material — between `30,000 and `35,000 — would be slashed by half using India-made implants.

CV Seshadri, MD, SMBPL said, “This sack is harvested and processed with biomaterial for ten days followed by quality control parameters to ensure it is microbial free. In India, chemicals like glutaraldehyde or formaldehyde are used, which are toxic and harmful, causing post complications in patients;  12 of 13 have congenital heart defect. Most of them do not get proper treatment.”

Follow The New Indian Express channel on WhatsApp


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp